NCT03347760 - Pilot Study Evaluating Somatostatin Receptor's PET Imaging to Detect Inflammatory Phases of Myocarditis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 13, 2020

Primary Completion Date

July 30, 2023

Study Completion Date

December 13, 2023

Conditions

Myocarditis

Interventions

DRUG

DOTATOC-68Ga PET initial

DOTATOC is a tracer of high affinity for the type 2 somatostatin receptors and is used for imaging of tumours which are expressing them, including endocrine tumours

DRUG

DOTATOC-68Ga PET at 6 months

DOTATOC is a tracer of high affinity for the type 2 somatostatin receptors and is used for imaging of tumours which are expressing them, including endocrine tumours

BIOLOGICAL

blood sample

blood tests will be carried out during the control visit to ensure that biological parameters are normalized

Trial Locations (1)

54511

Véronique ROCH, Vandœuvre-lès-Nancy

All Listed Sponsors

lead

Central Hospital, Nancy, France

OTHER